Abstract

Cellular blue nevus is extremely rare in the gynecologic tract with only 2 cases reported thus far, one in the myometrium and the other in the cervix/vagina/hymenal ring. In this report, we present the clinicopathologic features of the second case of cellular blue nevus arising in the myometrium. The patient was a 48-year-old woman who underwent a hysterectomy with bilateral salpingo-oophorectomy for uterine leiomyomas. On gross examination, the uterus showed a subserosal, 1.0×0.5×0.3 cm, dark red nodule in the anterior uterine wall in addition to multiple leiomyomas. Microscopically, the subserosal dark nodule had an irregular contour with only focal areas of pushing circumscribed border. The tumor cells were arranged either in sheets or confluent nests. The tumor cells were mostly epithelioid with clear cytoplasm, but in some areas the tumor cells were spindle-shaped with eosinophilic cytoplasm. Both types of cells contained intracytoplasmic melanin. The nuclei of the tumor cells were either oval, round, or elongated with no or minimal irregularities of the nuclear membrane, evenly distributed chromatin, inconspicuous nucleoli, and no obvious mitotic figures. Focally some of the epithelioid cells showed enlargement of the nucleus, irregularities in the nuclear contour, and rare nuclear pseudoinclusions. The tumor cells were positive for S-100, HMB-45 antigen (strong and diffuse pattern), and MART-1. Anti-Ki-67 showed a low proliferative activity (only a rare cell marked for this immunomarker). Thus, a diagnosis of cellular blue nevus was established. After a follow-up of 2 months, the patient had no evidence of the disease.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.